<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Basing on computer processing of 126 primary clinical and laboratory parameters obtained from 92 patients with <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> and using multifactorial regression analysis, the authors have developed prognostic models of life span and probability of transformation into <z:hpo ids='HP_0002488'>acute leukemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>The model of life span enabled recognition of 3 prognostic groups of <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> patients: of high (median 10 months), moderate (median 22 months) and low (median 35 months) risk </plain></SENT>
<SENT sid="2" pm="."><plain>This makes it possible to prognosticate the disease and assume optimal therapeutic policy </plain></SENT>
</text></document>